Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
AzurRx BioPharma to Present at the 2019 Annual Roth Capital Conference (March 19) and the Oppenheimer 29th Annual Healthcare Conference (March 20) | ||
By: Nasdaq / GlobeNewswire - 15 Mar 2019 | Back to overview list |
|
BROOKLYN, N.Y., March 15, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.(NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, announced today the Company will be making a company presentation at two upcoming investor conferences: the Annual Roth Capital Conference in Dana Point, California at the Ritz Carlton Hotel (Green Salon 3) on Tuesday, March 19th at 1:00 p.m. PST and at the 2019 Oppenheimer 29th Annual Healthcare Conference in New York City at the Westin Grand Central Hotel (Embassy Room) on Wednesday, March 20th at 2:10 p.m. EST. The company’s management will provide an overview of the Company's business during the live presentation and will be participating in one-on-one meetings with investors who are registered to attend the conference. |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |